263 related articles for article (PubMed ID: 27870604)
1. Immunoreactivity Analysis of the Nonstructural Proteins of Human Enterovirus 71.
Chen X; Qin B; Shi M; Zhu L; Sun M; Liu X; Zhang J
Viral Immunol; 2017 Mar; 30(2):106-110. PubMed ID: 27870604
[TBL] [Abstract][Full Text] [Related]
2. Screening and Identification of Linear B Cell Epitopes Within the Nonstructural Proteins of Enterovirus 71.
Zhang J; Huang H; Xu L; Lou C; Pan M
Viral Immunol; 2019 Mar; 32(2):84-88. PubMed ID: 30523737
[TBL] [Abstract][Full Text] [Related]
3. Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients.
Aw-Yong KL; Sam IC; Koh MT; Chan YF
PLoS One; 2016; 11(11):e0165659. PubMed ID: 27806091
[TBL] [Abstract][Full Text] [Related]
4. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
5. Identification of specific antigenic epitope at N-terminal segment of enterovirus 71 (EV-71) VP1 protein and characterization of its use in recombinant form for early diagnosis of EV-71 infection.
Zhang J; Jiang B; Xu M; Dai X; Purdy MA; Meng J
Virus Res; 2014 Aug; 189():248-53. PubMed ID: 24952304
[TBL] [Abstract][Full Text] [Related]
6. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
7. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ
Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825
[TBL] [Abstract][Full Text] [Related]
9. A Polysaccharide Purified From
Lin YL; Shih C; Cheng PY; Chin CL; Liou AT; Lee PY; Chiang BL
Front Immunol; 2020; 11():561758. PubMed ID: 33117346
[TBL] [Abstract][Full Text] [Related]
10. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
11. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
[TBL] [Abstract][Full Text] [Related]
12. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
Huang KA; Huang PN; Huang YC; Yang SL; Tsao KC; Chiu CH; Shih SR; Lin TY
PLoS Pathog; 2020 Sep; 16(9):e1008857. PubMed ID: 32936838
[TBL] [Abstract][Full Text] [Related]
13. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
You L; Chen J; Cheng Y; Li Y; Chen YQ; Ying T; Turtle L; Yu H
PLoS Pathog; 2023 Jun; 19(6):e1011420. PubMed ID: 37262073
[TBL] [Abstract][Full Text] [Related]
14. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of EV-A71 neutralizing antibodies following the 2011 epidemic in HCMC, Vietnam.
Kuo FL; Khanh TH; Chung WY; Hung NT; Luo ST; Chang WC; Nhan LNT; Thinh LQ; Lee MS
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008124. PubMed ID: 32126083
[TBL] [Abstract][Full Text] [Related]
16. Immune responses against enterovirus A71 infection: Implications for vaccine success.
Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
[TBL] [Abstract][Full Text] [Related]
17. Safety and Immunogenicity of a Stable, Cold-Adapted, Temperature-Sensitive/Conditional Lethal Enterovirus A71 in Monkey Study.
Chua KB; Ng Q; Meng T; Jia Q
Viruses; 2021 Mar; 13(3):. PubMed ID: 33803356
[TBL] [Abstract][Full Text] [Related]
18. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
[TBL] [Abstract][Full Text] [Related]
19. The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.
Shen YS; Chow YH; Fang CY; Wu SR; Chen CH; Huang MH; Liao CL; Chiang JR; Liu CC
J Microbiol Immunol Infect; 2023 Dec; 56(6):1121-1128. PubMed ID: 37919172
[TBL] [Abstract][Full Text] [Related]
20. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
